An AS04-containing human papillomavirus (HPV) 16/18 vaccine for prevention of cervical cancer is immunogenic and well-tolerated in women 15-55 years old.

被引：0
|
作者：
Schwarz, T. F.
机构：
[1] Juliusspital, Wurzburg, Germany
[2] GlaxoSmithKline Inc, Rixensart, Belgium
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：50S / 50S
页数：1
相关论文
共 32 条
  • [1] Human papillomavirus (HPV) 16/18 l1 AS04 virus-like particle (VLP) cervical cancer vaccine is immunogenic and well-tolerated 18 months after vaccination in women up to age 55 years
    Schwarz, T. F.
    Dubin, G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] Persistence of immune response to HPV-16/18 AS04-adjuvanted cervical cancer vaccine in women aged 15-55 years
    Schwarz, Tino F.
    Spaczynski, Marek
    Schneider, Achim
    Wysocki, Jacek
    Galaj, Andrzej
    Schulze, Karin
    Poncelet, Sylviane
    Catteau, Gregory
    Thomas, Florence
    Descamps, Dominique
    [J]. HUMAN VACCINES, 2011, 7 (09): : 958 - 965
  • [3] Immunogenicity and tolerability of an HPV-16/18 AS04-adjuvanted prophylactic cervical cancer vaccine in women aged 15-55 years
    Schwarz, Tino F.
    Spaczynski, Marek
    Schneider, Achim
    Wysocki, Jacek
    Galaj, Andrzej
    Perona, Pamela
    Poncelet, Sylviane
    Zahaf, Toufik
    Hardt, Karin
    Descamps, Dominique
    Dubin, Gary
    [J]. VACCINE, 2009, 27 (04) : 581 - 587
  • [4] Human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for the prevention of cervical cancer and HPV-related diseases
    Skinner, S. Rachel
    Apter, Dan
    De Carvalho, Newton
    Harper, Diane M.
    Konno, Ryo
    Paavonen, Jorma
    Romanowski, Barbara
    Roteli-Martins, Cecilia
    Burlet, Nansa
    Mihalyi, Attila
    Struyf, Frank
    [J]. EXPERT REVIEW OF VACCINES, 2016, 15 (03) : 367 - 387
  • [5] Human papillomavirus 16/18 AS04-adjuvanted cervical cancer vaccine: immunogenicity and safety in 15-25 years old healthy Korean women
    Kim, Seung Cheol
    Song, Yong Sang
    Kim, Young-Tae
    Kim, Young Tak
    Ryu, Ki-Sung
    Gunapalaiah, Bhavyashree
    Bi, Dan
    Bock, Hans L.
    Park, Jong-Sup
    [J]. JOURNAL OF GYNECOLOGIC ONCOLOGY, 2011, 22 (02) : 67 - 75
  • [6] Safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for cervical cancer prevention A pooled analysis of 11 clinical trials
    Descamps, Dominique
    Hardt, Karin
    Spiessens, Bart
    Izurieta, Patricia
    Verstraeten, Thomas
    Breuer, Thomas
    Dubin, Gary
    [J]. HUMAN VACCINES, 2009, 5 (05): : 332 - 340
  • [7] Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18
    Szarewski, A.
    Poppe, W. A. J.
    Skinner, S. R.
    Wheeler, C. M.
    Paavonen, J.
    Naud, P.
    Salmeron, J.
    Chow, S-N.
    Apter, D.
    Kitchener, H.
    Castellsague, X.
    Teixeira, J. C.
    Hedrick, J.
    Jaisamrarn, U.
    Limson, G.
    Garland, S.
    Romanowski, B.
    Aoki, F. Y.
    Schwarz, T. F.
    Bosch, F. X.
    Harper, D. M.
    Hardt, K.
    Zahaf, T.
    Descamps, D.
    Struyf, F.
    Lehtinen, M.
    Dubin, G.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (01) : 106 - 116
  • [8] Vaccination with a Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Cervical Cancer Vaccine in Korean Girls Aged 10-14 Years
    Kim, Young-Jae
    Kim, Kyung-Tai
    Kim, Jae-Hoon
    Cha, Soon-Do
    Kim, Jae Weon
    Bae, Duk-Soo
    Nam, Joo-Hyun
    Ahn, Woong-Shick
    Choi, Ho-Sun
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2010, 25 (08) : 1197 - 1204
  • [9] Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine in healthy Indian women
    Bhatla, Neerja
    Suri, Vanita
    Basu, Partha
    Shastri, Surendra
    Datta, Sanjoy K.
    Bi, Dan
    Descamps, Dominique J.
    Bock, Hans L.
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2010, 36 (01) : 123 - 132
  • [10] AS04-Adjuvanted Human Papillomavirus (HPV) Types 16 and 18 Vaccine (Cervarix®) A Review of its Use in the Prevention of Premalignant Cervical Lesions and Cervical Cancer Causally Related to Certain Oncogenic HPV Types
    McKeage, Kate
    Romanowski, Barbara
    [J]. DRUGS, 2011, 71 (04) : 465 - 488
1234